| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/29/2007 | CN100333793C Diploid-cell rabies vaccine and purified rabies vaccine, freeze-drying preparation and water injection thereof |
| 08/29/2007 | CN100333792C Rsv基因表达疫苗 Rsv gene expression vaccine |
| 08/29/2007 | CN100333791C Methods for vaccinating against malaria |
| 08/28/2007 | US7262286 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 08/28/2007 | US7262277 Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 08/28/2007 | US7262276 Two polypeptide domains connected by a polypeptide linker, one is anti-ovarian cancer antibody, or its Fab fragment, single complementarity determining region (CDR) antibody or single chain Fv (scFv) and the other is anti-CD3 antibody, or its Fab fragment, single CDR antibody or scFv |
| 08/28/2007 | US7262274 Kit which detects ligand associated with nuclear factor kappa beta receptor for treating toxic shock, sepsis, inflammation and graft vs host disease |
| 08/28/2007 | US7262272 Epitope from an alpha -helical surface region of a protein inserted into a coiled-coil polypeptide template; conformation-specific antibodies can be generated for use as therapeutic and diagnostic ligand. |
| 08/28/2007 | US7262271 Immunogens as well as antibodies |
| 08/28/2007 | US7262270 Ectodomain of the HIV-1IIIB envelope glycoprotein gp41 fused to a fragment of the influenza virus HA2 hemagglutinin protein. Immunization in vivo via an intraperitoneal prime followed by intranasal or intragastric boosts with gp41HA |
| 08/28/2007 | US7262267 Polypeptide mediating cell permeability |
| 08/28/2007 | US7262167 Treating tumors and other conditions in a patient is provided. The method involves administering to the patient a treatment medicament. The medicament contains a first component and a second component. The first component can be a quantity of |
| 08/28/2007 | US7262062 Identifying monoclonal antibody for use in prevention and treatment of skin disorers; immunotherapy and peptide mimetics |
| 08/28/2007 | US7262050 Humanised antibodies |
| 08/28/2007 | US7262045 Methods of producing influenza vaccine compositions |
| 08/28/2007 | US7262044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/28/2007 | US7262028 Recombinant production of mixtures of antibodies |
| 08/28/2007 | US7262027 Polypeptide and DNA immunization against Coccidioides spp. infections |
| 08/28/2007 | US7262024 Comprises nucleotide sequences coding polypeptides for diagnosis, prevention and treatment of meningitis, inflammations, bacterial and pneumonia infections |
| 08/28/2007 | US7262014 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins |
| 08/28/2007 | US7261901 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 08/28/2007 | US7261900 Generating imunoglobulins for prevention and treatment anthrax infection; genetic vaccines and biological warfare agents |
| 08/28/2007 | US7261899 Method of producing thy A-strains of Vibrio cholerae, such strains and their use |
| 08/28/2007 | US7261898 Modulating replication via immunogen and pharmaceutically or veterinarily acceptable vehicles |
| 08/28/2007 | US7261897 Fusion proteins of mycobacterium tuberculosis |
| 08/28/2007 | US7261896 Methods for preventing strokes by inducing tolerance to e-selectin |
| 08/28/2007 | US7261895 Peptide tag for monitoring and purification of proteins |
| 08/28/2007 | US7261894 Administering an antagonistic antibody immunoreactive with IL-1 epsilon for therapy of inflammatory and/or autoimmune disease selected from the group consisting of asthma, inflammatory bowel disease, psoriasis, and combinations thereof |
| 08/28/2007 | US7261893 Neutralizing antibodies against GDF-8 and uses therefor |
| 08/28/2007 | US7261892 Administering an antibody that specifically binds to CD27L for therapy of renal cell carcinoma |
| 08/28/2007 | US7261891 Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease |
| 08/28/2007 | US7261890 Methods for using canine immunoglobulin variable domains and caninized antibodies |
| 08/28/2007 | US7261884 Administering to the host a live Plasmodium organism that is genetically engineered to disrupt a gene whose expression is up-regulated in infective salivary gland sporozoites and whose function is not required for entry into host hepatocytes |
| 08/28/2007 | US7261883 Vaccines containing ribavirin and methods of use thereof |
| 08/28/2007 | CA2148253C Allergenic proteins and peptides from johnson grass pollen |
| 08/28/2007 | CA2124460C Production of anti-self antibodies from segment repertoires and displayed on phage |
| 08/28/2007 | CA2123355C Preparation and uses of los-depleted outer membrane proteins of gram-negative cocci |
| 08/24/2007 | CA2568981A1 Integrase-derived hiv-inhibiting agents |
| 08/23/2007 | WO2007095320A2 Hpv antigens, vaccine compositions, and related methods |
| 08/23/2007 | WO2007095069A2 Nf-ya activates multiple hematopoietic stem cell (hsc) regulatory genes and promotes hsc self-renewal |
| 08/23/2007 | WO2007094924A2 Human telomerase reverse transcriptase peptides |
| 08/23/2007 | WO2007094916A2 Non-natural amino acid polypeptides having modulated immunogenicity |
| 08/23/2007 | WO2007094776A1 Compositions and methods for suppressing fibrocyte differentiation |
| 08/23/2007 | WO2007094668A1 Affinity regions |
| 08/23/2007 | WO2007094462A1 Non-human animal having modified genome or offspring thereof |
| 08/23/2007 | WO2007094423A1 Human monoclonal antibody capable of binding to human cytomegalovirus, and antigen-binding domain of the antibody |
| 08/23/2007 | WO2007094137A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine |
| 08/23/2007 | WO2007093630A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies |
| 08/23/2007 | WO2007093472A1 Dengue chimeric viruses |
| 08/23/2007 | WO2007093134A1 Aids vaccine based on replicative vaccinia virus vector |
| 08/23/2007 | WO2007093133A1 Sars vaccine based on replicative vaccinia virus vector |
| 08/23/2007 | WO2007093042A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 08/23/2007 | WO2007093008A1 Antibodies to insulin-like growth factor i receptor |
| 08/23/2007 | WO2007071839A3 Potentiation of apoptosis by monoclonal antibodies |
| 08/23/2007 | WO2007068411A3 Therapeutic vaccine |
| 08/23/2007 | WO2007067597A3 Methods and compositions for needleless delivery of binding partners |
| 08/23/2007 | WO2007059136A3 Rankl antibody-pth/pthrp chimeric molecules |
| 08/23/2007 | WO2007050866A3 Oligodendrocyte-myelin glycoprotein compositions and methods of use thereof |
| 08/23/2007 | WO2007044695A3 ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF |
| 08/23/2007 | WO2007039150A3 Cell populations having immunoregulatory activity, method for isolation and uses |
| 08/23/2007 | WO2007038282A3 Stabilization of clostridium botulinum neurotoxin complex |
| 08/23/2007 | WO2007015935A3 Diagnostic methods for the prediction of therapeutic success, recurrence free and overall survival in cancer therapy |
| 08/23/2007 | WO2007007352A3 A vaccine for staphylococcal infections |
| 08/23/2007 | WO2006128689A3 Therapeutic composition for use in the prevention and treatment of bone metastases |
| 08/23/2007 | WO2006126068A3 Recombinant method for the production of a monoclonal antibody to cd52 for the treatment of chronic lymphocytic leukemia |
| 08/23/2007 | WO2006116369A3 Method for treating dementia or alzheimer's disease with a cd20 antibody |
| 08/23/2007 | WO2006113139A3 Method of altering the binding specificity of proteins by oxidation-reduction reactions |
| 08/23/2007 | WO2006089015A3 Methods of using death receptor agonists and egfr inhibitors |
| 08/23/2007 | WO2006088494A3 Identification and engineering of antibodies with variant fc regions and methods of using the same |
| 08/23/2007 | WO2006067122A3 Binding molecules capable of neutralizing west nile virus and uses thereof |
| 08/23/2007 | WO2006060664A3 Single-drug multi-ligand conjugates for targeted drug delivery |
| 08/23/2007 | WO2006036962A3 Compositions and methods for modulating tissue regeneration and chemotactic responses |
| 08/23/2007 | WO2005107817A3 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 08/23/2007 | WO2005067629A3 Cancer-linked genes as targets for chemotherapy |
| 08/23/2007 | WO2004018698A3 Lectin compositions and methods for modulating an immune response to an antigen |
| 08/23/2007 | WO2002097035A3 Secreted proteins |
| 08/23/2007 | WO2002018595A9 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 08/23/2007 | US20070199078 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 08/23/2007 | US20070197432 fusion protein comprising an amino acid sequence coupled to a single carrier keyhole limpet hemocyanin (KLH) protein and the bovine serum albumin (BSA) protein; vaccines; veterinary medicine |
| 08/23/2007 | US20070196931 selectively kill Fusobacterium varium cells, or neutralize the toxin produced by Fusobacterium varium cells; differential diagnosis between ulcerative colitis and inflammatory bowel disease |
| 08/23/2007 | US20070196916 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 08/23/2007 | US20070196462 Composition and method for neuromuscular blockade |
| 08/23/2007 | US20070196394 Immunogenic compositions comprising Liver Stage Malarial Antigens |
| 08/23/2007 | US20070196393 Recombinant Neospora antigens and their uses |
| 08/23/2007 | US20070196392 Development of a Chlamydia sp. vaccine strain |
| 08/23/2007 | US20070196391 Mucosal boosting following parenteral priming |
| 08/23/2007 | US20070196390 Equine herpesvirus vaccine |
| 08/23/2007 | US20070196389 Viral gene products and methods for vaccination to prevent viral associated diseases |
| 08/23/2007 | US20070196388 Cold-adapted equine influenza viruses |
| 08/23/2007 | US20070196387 Novel assay for the separation and quantification of hemagglutinin antigens |
| 08/23/2007 | US20070196386 Mutant murine leukemia virus proteus with amino acid substitution; infection efficiency; generating mutant library; gene expression |
| 08/23/2007 | US20070196385 Method of treating hepatitis C infection |
| 08/23/2007 | US20070196384 Novel glycolipid adjuvant compositions |
| 08/23/2007 | US20070196380 Extracellular matrix to treat malignancy in mammals |
| 08/23/2007 | US20070196379 Methods for treating congestive heart failure |
| 08/23/2007 | US20070196378 Hyphae-Specific Cell Wall Proteins Of Candida |
| 08/23/2007 | US20070196377 polynucleotide; rho genes rho proteins; guanosine triphosphate binding proteins; antibody against the protein encodes polynucleotide; detection and treating stomach tumor; determining a disease, a pharmaceutical composition, and a reagent kit |
| 08/23/2007 | US20070196376 Binding proteins specific for insulin-like growth factors and uses thereof |
| 08/23/2007 | US20070196375 Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers |
| 08/23/2007 | US20070196374 Immunoglobulins which binding to endothelial growth factor for therapy for cell proliferative disorders; antitumor agents |